Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Other Non-Current Assets (2016 - 2025)

Ptc Therapeutics has reported Other Non-Current Assets over the past 14 years, most recently at $18.3 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $18.3 million for Q4 2025, down 11.6% from a year ago — trailing twelve months through Dec 2025 was $18.3 million (down 11.6% YoY), and the annual figure for FY2025 was $18.3 million, down 11.6%.
  • Other Non-Current Assets for Q4 2025 was $18.3 million at Ptc Therapeutics, down from $19.4 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for PTCT hit a ceiling of $75.2 million in Q1 2021 and a floor of $18.3 million in Q4 2025.
  • Median Other Non-Current Assets over the past 5 years was $35.9 million (2023), compared with a mean of $39.7 million.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 133.56% in 2021 and later plummeted 48.73% in 2024.
  • Ptc Therapeutics' Other Non-Current Assets stood at $46.5 million in 2021, then increased by 4.48% to $48.6 million in 2022, then dropped by 25.39% to $36.2 million in 2023, then crashed by 42.88% to $20.7 million in 2024, then decreased by 11.6% to $18.3 million in 2025.
  • The last three reported values for Other Non-Current Assets were $18.3 million (Q4 2025), $19.4 million (Q3 2025), and $21.8 million (Q2 2025) per Business Quant data.